The epidemic of erythromycin-resistant Bordetella pertussis with limited genome variation associated with pertussis resurgence in China

Expert Rev Vaccines. 2020 Nov;19(11):1093-1099. doi: 10.1080/14760584.2020.1831916. Epub 2020 Oct 21.

Abstract

Background: The resurgence of Bordetella pertussis infections leading to whooping cough is a concern in many parts of the world. The number of pertussis cases in China has increased significantly since 2013.

Research design and methods: In this study, whole-genome sequencing analysis was performed for 388 B. pertussis strains isolated in China from the 1970s to 2018, combining 594 published strains from around the world.

Results: This study revealed that lineage V diverged about 50 years ago in China, while lineage IV is dominant in the other countries. It also revealed that the erythromycin-resistant sub-lineages Va, Vb, and Vc with limited genomic variation emerged 11 ~ 12 years ago. These three sub-lineages were identified after the co-purified acellular vaccines (cp-ACVs) completely replaced the previous whole cell vaccines (WCVs) after the national immunization program of 2012. It suggests that the cp-ACVs cannot induce immunity that is potent enough to restrict the spread of the lineage V, antibiotic abuse further favors the spread of this lineage in China.

Conclusions: These findings demand a reassessment of the immunization strategy and development of new vaccines in China to stop the resurgence and drug resistance of B. pertussis.

Keywords: Bordetella pertussis; SNP; erythromycin resistance; vaccine; whole genome analysis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Bordetella pertussis / drug effects
  • Bordetella pertussis / genetics
  • Bordetella pertussis / isolation & purification*
  • China / epidemiology
  • Drug Resistance, Bacterial
  • Erythromycin / pharmacology*
  • Humans
  • Immunization Programs
  • Pertussis Vaccine / administration & dosage*
  • Vaccines, Acellular / administration & dosage
  • Whole Genome Sequencing
  • Whooping Cough / epidemiology*
  • Whooping Cough / microbiology
  • Whooping Cough / prevention & control

Substances

  • Anti-Bacterial Agents
  • Pertussis Vaccine
  • Vaccines, Acellular
  • Erythromycin